A Stanford-led study found that most AI chatbots have stopped including medical disclaimers in health responses, raising ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

Among new hires, former Google Gemini engineering lead Amar Subramanya joined Microsoft AI as corporate vice-president.

Artificial intelligence startup OpenEvidence banked a $210 million series B round as it looks to expand its strategic content ...

It’s a sentiment felt widely across the medical field as AI starts to touch nearly every corner of medical research, physician training and processes, and patient care. The rollout of AI across health ...

OpenEvidence, dubbed the 'ChatGPT for doctors,' uses AI to simplify evidence-based medical information for physicians, now ...

Microsoft's new model-agnostic MAI Diagnostic Orchestrator (MAI-DxO) achieved 85.5 percent diagnostic accuracy—outperforming ...

Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...

Google DeepMind subsidiary, Isomorphic Labs, has said it is ready to conduct human trials for drugs developed using its AlphaFold AI technology.

After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the ...